LOTUSEYE

Lotus Eye Hospital And Institute Share PriceLotus Eye Hospital and Institute

₹58.6
1.1 (1.91%)
As on 01 April, 2023 | 12:55 BSE: 532998 NSE: LOTUSEYE

Lotus Eye Hospital And Institute Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Lotus Eye Hospital and Institute

Start SIP

Lotus Eye Hospital And Institute Share Price

  • Over 1 Month -5.02%
  • Over 3 Month -23.45%
  • Over 6 Month -16.46%
  • Over 1 Year 10.57%

Lotus Eye Hospital And Institute Key Statistics

P/E Ratio 30.7
PEG Ratio 2.6
Market Cap Cr 122
Price to Book Ratio 2.2
EPS 1.4
Dividend 0.9
Relative Strength Index 37.72
Money Flow Index 44.84
MACD Signal -2.37
Average True Range 3.6

Lotus Eye Hospital And Institute Investment Rating

  • Master Rating:
  • Lotus Eye Hospital And Institute has an operating revenue of Rs. 46.44 Cr. on a trailing 12-month basis. An annual revenue growth of 20% is outstanding, Pre-tax margin of 11% is healthy, ROE of 5% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 65 which is a FAIR score but needs to improve its earnings, a RS Rating of 45 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 46 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of D is close to being the worst. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Lotus Eye Hospital and Institute Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 12121211
Operating Expenses Qtr Cr 1010109
Operating Profit Qtr Cr 2221
Depreciation Qtr Cr 1111
Interest Qtr Cr 0000
Tax Qtr Cr 0000
Net Profit Qtr Cr 1111

Lotus Eye Hospital And Institute Technicals

EMA & SMA

Current Price
₹58.6
1.1 (1.91%)
  • Bullish Moving Average
  • ___
  • 2
  • Bearish Moving Average
  • ___
  • 14
  • 20 Day
  • 61.12
  • 50 Day
  • 65.59
  • 100 Day
  • 68.59
  • 200 Day
  • 67.43
  • 20 Day
  • 61.08
  • 50 Day
  • 66.23
  • 100 Day
  • 73.42
  • 200 Day
  • 69.02

Lotus Eye Hospital And Institute Resistance and Support

PIVOT
₹58.12
Resistance
First Resistance 59.89
Second Resistance 62.27
Third Resistance 64.04
RSI 37.72
MFI 44.84
MACD Single Line -2.37
MACD -2.36
Support
First Resistance 55.74
Second Resistance 53.97
Third Resistance 51.59

Lotus Eye Hospital And Institute Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 2,469 177,299 71.81
Week 6,154 454,676 73.88
1 Month 6,825 438,587 64.26
6 Month 37,486 2,112,715 56.36

Lotus Eye Hospital And Institute Result Highlights

Lotus Eye Hospital and Institute Synopsis

NSE-Medical-Hospitals

Lotus Eye Hospital belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 38.91 Cr. and Equity Capital is Rs. 20.80 Cr. for the Year ended 31/03/2022. Lotus Eye Hospital and Institute Ltd. is a Public Limited Listed company incorporated on 14/03/1997 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L85110TZ1997PLC007783 and registration number is 007783.
Market Cap 122
Sales 46
Shares in Float 0.87
No of funds 1
Yield 0.85
Book Value 2.23
U/D Vol ratio 0.5
LTDebt / Equity
Alpha 0.11
Beta 1.09

Lotus Eye Hospital and Institute

Owner NameDec-22Sep-22Jun-22
Promoters 58.14%57.88%57.74%
Foreign Portfolio Investors
Individual Investors 21.8%23.13%27.13%
Others 20.06%18.99%15.13%

Lotus Eye Hospital and Institute Management

Name Designation
Dr. Kavetha Sundaramoorthy Chairman
Ms. Sangeetha Sundaramoorthy Managing Director
Dr. K S Ramalingam Executive Director & CEO
Mr. D R Kaarthikeyan Director
Dr. Yogesh Shah Director
CA. R Subramanian Director
CA. M Alagiriswamy Director
Dr. S Natesan Director

Lotus Eye Hospital And Institute Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Lotus Eye Hospital and Institute FAQs

What is Share Price of Lotus Eye Hospital and Institute ?

Lotus Eye Hospital and Institute share price is ₹58 As on 01 April, 2023 | 12:41

What is the Market Cap of Lotus Eye Hospital and Institute ?

The Market Cap of Lotus Eye Hospital and Institute is ₹121.9 Cr As on 01 April, 2023 | 12:41

What is the P/E ratio of Lotus Eye Hospital and Institute ?

The P/E ratio of Lotus Eye Hospital and Institute is 30.7 As on 01 April, 2023 | 12:41

What is the PB ratio of Lotus Eye Hospital and Institute ?

The PB ratio of Lotus Eye Hospital and Institute is 2.2 As on 01 April, 2023 | 12:41

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number